-
Drug shortages; metformin and cancer prevention; migraine prevention guidelines; and FDA actions.
-
-
Vorapaxar is a potent antiplatelet medication with a novel action that works by inhibiting thrombin activation of platelets through the protease-activated receptor PAR-1.
-
With the advent of specific genetic tests, atypical forms of facioscapulohumeral muscular dystrophy can be reliably diagnosed.
-
This study presents a large group of new cases of rhombencephalosynapsis and carefully describes correlations to other associated morphological abnormalities as well as to outcomes.
-
Of all ischemic stroke patients treated with iv al- teplase (tPA), only about half will achieve recanalization and have a good outcome (mRS 0 to 2).
-
Children with isolated growth hormone deficiency have lower IQ, worse motor skills, and several brain regions with smaller volumes than carefully selected controls.
-
New treatment for prostate cancer; avastin and breast cancer; new CMS disclosure rule; and FDA actions.
-
Detailed neuropathological investigation of patients with sensory neuronopathy and polymerase γ mutations revealed evidence of posterior column atrophy in spinal cord sections and marked neuronal cell loss with severe mitochondrial biochemical abnormalities (involving respiratory chain complexes I and IV) in the dorsal root ganglia.
-
Small fiber neuropathy (SFN) is a relatively common disorder that affects small somatic and/or autonomic nerves. Known causes include diabetes, vitamin B12 deficiency, and Sjogren's syndrome among others, although the condition is idiopathic in most cases.